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INTRODUCTION 
Tumor cells have a very distinctive metabolism. Several previous 
studies have considered the metabolic changes that take place in the host 
after tumor implantation. Metabolic abnormalities arising from 
malnutrition and malignancy are seen in animals or patients with cancer 
cachexia. Various cancers affect the lipid metabolism.1-7) Rats 
subcutaneously implanted with the ascites hepatoma cell line AH109A 
show hyperlipidemia with a notable decrease in the high-density 
lipoprotein (HDL) fraction and an enormous increase in the very-low-
density lipoprotein (VLDL) plus low-density lipoprotein (LDL) 
fractions5-7) during growth of the solid tumor.5) AH109A is a hepatoma 
and originates from the liver. Major lipid metabolism occurs in the liver; 
this includes cholesterol, fatty acid, and triglyceride biosyntheses as well 
as VLDL production. It is therefore believed that hepatoma cells may 
affect the lipid metabolism in the host body and that the cancer state 
affects the lipid metabolism. 
Sato lung carcinoma (SLC) is a transplantable solid pulmonary 
tumor induced in a male Donryu strain rat with 4-nitroquinoline 1-oxide. 
SLC cells injected intravenously have been found to produce metastatic 
foci only in the lung, with all injected rats dying of pulmonary 
metastases.8,9) 
In the present study, to investigate the effects of the SLC implantation 
on lipid metabolism, changes in lipid levels in the serum and liver were 
examined in SLC-implanted rats. A previous study reported that SLC-
bearing rats implanted with 5×106 cells showed a decrease in the serum 
HDL- and esterified cholesterol concentrations. The solid tumor was 
observed within a short time after SLC implantation, although the solid 
tumor stopped growing and the solid tumor weight was less than 1% of 
the body weight on the 21st day after SLC implantation.10) Therefore, in 
the present study, rats were implanted with 5×107 SLC cells or 5×106 
SLC cells to investigate the effects of the number of tumor cells 
implanted on serum and liver lipid levels. 
 
MATERIALS AND METHODS 
Animals and diets. This animal experiment was conducted with the 
approval of the Iwate Prefectural University Research Ethics Committee. 
Male Donryu rats (four weeks of age, Japan SLC, Inc., Shizuoka, 
Japan) were individually housed in stainless steel cages with wire 
bottoms in an air-conditioned room with a temperature of 22±2℃, a 
relative humidity of 55±5%, and an 8:00 a.m. to 8:00 p.m. light cycle 
and were fed a stock pellet diet (MF; Oriental Yeast Co., Ltd., Tokyo, 
Japan) followed by a basal diet containing 20% casein.11) The 
composition of the basal diet was as follows: 20% casein (Oriental Yeast 
Co., Ltd.), 13.2% α-cornstarch (Oriental Yeast Co., Ltd.), 39.75% 
cornstarch (Oriental Yeast Co., Ltd.), 10% sucrose (Nissin Sugar 
Manufacturing Co., Tokyo, Japan), 5% cellulose powder (Oriental Yeast 
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Co., Ltd.), 7% soybean oil (Oriental Yeast Co., Ltd.), 3.5% mineral 
mixture (AIN 93G composition)11) (Oriental Yeast Co., Ltd.), 1% 
vitamin mixture (AIN 93 composition)11) (Oriental Yeast Co., Ltd.), 
0.25% choline bitartrate (Wako Pure Chemical Industries, Ltd., Osaka, 
Japan), and 0.3% L-cystine (Wako Pure Chemical Industries, Ltd.). 
After preliminary feeding, the rats were divided into three groups (n=7) 
of similar body weights. Two of the groups received a subcutaneous 
implantation of 5×106 (T6 group) or 5×107 (T7 group) SLC cells 
(provided by the Cell Resource Center for Biomedical Research, 
Institute of Development, Aging and Cancer, Tohoku University, Sendai, 
Japan) suspended in phosphate-buffered saline (PBS(-)) (0.5 ml/rat) in 
the back to produce a solid tumor (tumor-bearing group), and the last 
group received a sham injection of PBS(-) alone (0.5 ml/rat); this latter 
group was designated normal rats (C group). The SLC cells were 
prepared by means of a cell culture system. The SLC cells were cultured 
in RPMI-1640 medium supplemented with 10% fetal calf serum. The 
rats of each group were maintained for a further 21 days on the basal diet. 
The solid tumor diameter was measured to estimate the tumor volume 
every day. Water and diet were offered every day and remained available 
at all times. The animals were deprived of their diet at 9:00 a.m. on the 
21st day, but allowed free access to water until they were sacrificed, 
which was done 4 hours later. Blood was collected and left to clot at 
room temperature to obtain serum. The liver, epididymal adipose tissue, 
and solid tumor were quickly removed, washed with cold 0.9% NaCl, 
blotted on filter paper, and weighed. The serum and liver were stored at 
-30℃ until lipid concentration analyses were performed. Aliquots of the 
liver were also preserved in methanol and stored at 4℃ until analyses of 
the lipid contents were performed. 
Lipid analyses. The lipoprotein separation of serum was as follows, 
HDL was separated from VLDL plus LDL by precipitation method 
using sodium phosphotungstic acid and MgCl,12) and VLDL was 
separated from LDL plus HDL by ultracentrifugation.13) 
Serum total, HDL-, and (HDL+LDL)-cholesterol, free cholesterol, 
triglyceride, phospholipid, and nonesterified fatty acid (NEFA) 
concentrations were determined by an enzymatic method using a 
Cholesterol E-test, Free cholesterol E-Test, Triglyceride E-test, 
Phospholipid C-test, and NEFA C-test (Wako Pure Chemical Industries, 
Ltd.), respectively. The difference between the total cholesterol 
concentration and HDL-cholesterol concentration was regarded as the 
(VLDL+LDL)-cholesterol concentration. The difference between the 
(HDL+LDL)-cholesterol concentration and HDL-cholesterol concen-
tration was regarded as the LDL-cholesterol concentration. The 
difference between the (VLDL+LDL)-cholesterol concentration and 
LDL-cholesterol concentration was regarded as the VLDL-cholesterol 
concentration. The ratio of the (VLDL+LDL)-cholesterol concentration 
to HDL-cholesterol concentration is designated as the atherogenic index. 
The difference between the total cholesterol concentration and free 
cholesterol concentration was regarded as the esterified cholesterol 
concentration, and the ratio of the esterified cholesterol concentration to 
total cholesterol concentration is designated as the cholesterol ratio. 
Total lipids were extracted according to the procedure of Folch et 
al.14) from the liver. After portions of the chloroform phase had been 
dried under nitrogen, the contents of cholesterol,15) triglyceride,16) and 
phospholipid17) were determined. 
Table 1. Initial body weight, food intake, body weight gain, and weights of liver and epididymal adipose tissue in normal (Control) and 
tumor-bearing rats. 
Measurement                     Control              Tumor-bearing 
                                   5×106 cells       5×107 cells 
Initial body weight (g)              154.2 ± 2.6        154.2 ± 2.4        154.2 ± 2.2 
Food intake (g/21d)               469.1± 8.4         479.6 ± 12.5       480.5 ± 8.2 
Body weight gain (g/21d)             190.6 ± 2.7         194.7 ± 6.0       193.5 ± 3.8 
Liver weight (g/whole body)            16.2 ± 0.4         17.1 ± 0.7        17.4 ± 0.5 
Epididymal adipose tissue weight (g/whole body)   5.41 ± 0.31        5.23 ± 0.27       5.15 ± 0.19 
Values represent the means ± standard errors for seven rats. 
 
 
 
 
Fig. 1. Estimated solid tumor volume in tumor-bearing rats implanted 
5×106 (■) or 5×107 (●) SLC cells. Each value represents the 
means for seven rats. Vertical bars indicate standard errors. 
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The serum and liver thiobarbituric acid-reactive substance (TBARS) 
values were measured according to the method described by Yagi18) and 
Mihara et al.,19) respectively. 
Statistical analysis. Results were expressed as mean ± standard error. 
Statistical analysis was carried out by one-way analysis of variance 
followed by Dunnett’s pairwise multiple comparison t-test using the 
SPSS Statistics, version 22 (IBM Japan, Ltd., Tokyo, Japan). A 
significance level of p < 0.05 was used for all the comparisons. 
 
RESULTS 
Table 1 shows the initial body weight, food intake, and body weight 
gain for the 21-day duration of the experimental period and the weights 
of the liver and epididymal adipose tissue at the end of the experimental 
period. There were no significant differences between the control group 
 
Fig. 2. Serum cholesterol concentration, atherogenic index, and cholesterol ratio in normal and tumor-bearing rats. Each value represents the means 
for seven rats. Vertical bars indicate standard errors. * Significantly different from the control group at p < 0.05 by one-way analysis of variance 
followed by Dunnett’s pairwise multiple comparison t-test. C, normal rats group (Control); T6, tumor-bearing rats implanted 5×106 SLC cells group; 
T7, tumor-bearing rats implanted 5×107 SLC cells group. 
 
 Fig. 3. Serum triglyceride, phospholipid, and nonesterified fatty acid (NEFA) concentrations in normal and tumor-bearing rats. Each value represents 
the means for seven rats. Vertical bars indicate standard errors. C, normal rats group (Control); T6, tumor-bearing rats implanted 5×106 SLC cells 
group; T7, tumor-bearing rats implanted 5×107 SLC cells group. 
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and each of the two tumor-bearing groups (C vs. T6 and C vs. T7) with 
regard to food intake, body weight gain, and liver and epididymal 
adipose tissue weights. 
The absolute and relative weights of the solid tumors at the end of 
the experimental period in groups T6 and T7 were 0.44 ± 0.07 g and 0.12 
± 0.02 % of body weight, respectively, in the T6 group, and 0.97 ± 0.21 
g and 0.28 ± 0.06 % of body weight, respectively, in the T7 group. 
Fig. 1 shows the estimated solid tumor volume in tumor-bearing rats 
after SLC implantation. The solid tumor could be observed on day 36 
(T6 group) or day 2-4 (T7 group) after SLC implantation and continued 
to grow with time. On approximately the 14th day after SLC 
implantation, however, the solid tumor stopped growing and began to 
decrease in size until the 21st day after SLC implantation. 
The serum cholesterol concentrations are shown in Fig. 2. The total 
cholesterol concentration in the tumor-bearing rats decreased 
significantly as compared to the control group (C vs. T6 and C vs. T7). 
In lipoprotein cholesterol, the HDL-cholesterol concentrations in each of 
the two tumor-bearing groups was significantly lower than that in the 
control group (C vs. T6 and C vs. T7), while the LDL- and VLDL-
cholesterol concentrations were not changed in response to tumor 
bearing. The atherogenic index in the two tumor-bearing groups was not 
significantly changed as compared to the control group (C vs. T6 and C 
vs. T7). The esterified cholesterol concentration in each of the two tumor-
bearing groups was significantly lower than that in the control group (C 
vs. T6 and C vs. T7), while the free cholesterol concentration was not 
changed in response to tumor-bearing. The cholesterol ratio in the two 
tumor-bearing groups was not significantly changed as compared to the 
control group (C vs. T6 and C vs. T7). 
The serum triglyceride, phospholipid, and NEFA concentrations are 
shown in Fig. 3. There were no significant differences between the 
control group and each of the two tumor-bearing groups (C vs. T6 and C 
vs. T7) with regard to the serum triglyceride, phospholipid, and NEFA 
 
Fig. 4. Liver lipid contents in normal and tumor-bearing rats. Each value represents the means for seven rats. Vertical bars indicate standard errors. 
C, normal rats group (Control); T6, tumor-bearing rats implanted 5×106 SLC cells group; T7, tumor-bearing rats implanted 5×107 SLC cells group. 
 
 
Fig. 5. Serum and liver thiobarbituric acid-reactive substance (TBARS) values in normal and tumor-bearing rats. Each value represents the means 
for seven rats. Vertical bars indicate standard errors. C, normal rats group (Control); T6, tumor-bearing rats implanted 5×106 SLC cells group; T7, 
tumor-bearing rats implanted 5×107 SLC cells group. 
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concentrations. 
   The liver lipid contents are shown in Fig. 4. The liver cholesterol, 
triglyceride, and phospholipid contents were not significantly different 
between the control group and each of the two tumor-bearing groups (C 
vs. T6 and C vs. T7). 
   The serum and liver TBARS values are shown in Fig. 5. There were 
no significant differences between the control group and each of the two 
tumor-bearing groups (C vs. T6 and C vs. T7) with regard to the serum 
and liver TBARS values. 
 
DISCUSSION 
The implantation of both 5×106 and 5×107 SLC cells in rats 
significantly decreased the total cholesterol concentration, especially the 
esterified cholesterol and HDL-cholesterol concentrations, as compared 
to the control group. The free cholesterol esterification is catalyzed by 
lecithin-cholesterol acyl transferase (LCAT). LCAT catalyzes the 
transfer of a fatty acid residue from the 2-position of lecithin to 
cholesterol to form esterified cholesterol and is considered to be 
responsible for much of the esterified cholesterol in plasma lipoproteins. 
It is likely that, in the rats that received the SLC implantation, the 
esterification of free cholesterol might be reduced by the suppression of 
the LCAT activity, and, hence, the decrease in the serum esterified 
cholesterol concentration was investigated. LCAT is also an important 
enzyme in reverse cholesterol transport, as it plays a central role in the 
transport of excess cholesterol from peripheral tissues to HDL. It has 
been reported that a significant decrease in plasma HDL-cholesterol 
concentration and a suppression of plasma LCAT activity occur 
simultaneously in hemodialysis patients.20) It is considered that if the 
suppression of serum LCAT activity occurs, it might be the cause of the 
significant decrease in serum HDL-cholesterol concentration seen in 
SLC-implanted rats. 
It is well known that some cancers affect lipid metabolism. For 
example, an increase in the serum total cholesterol and (VLDL+LDL)-
cholesterol concentrations and a decrease in the serum HDL-cholesterol 
concentration were seen in rats bearing the ascites hepatoma cell line 
AH109A.5-7) The plasma TBARS value increased in oral cancer 
patients.21) In the present study, the SLC implantation did not cause a 
change in most of the parameters related to lipid metabolism other than 
the above-mentioned measurements. In the tumor-bearing state, 
disorders of lipid metabolism occurred during the growth of the solid 
tumor.5) In a previous study, tumor-bearing rats showed increased plasma 
triglyceride concentration and suppressed activities of tissue lipoprotein 
lipase, the hydrolytic enzyme in serum triglyceride, with increased tumor 
burden, and tumor removal completely reversed these changes.22) These 
studies provide evidence that the tumor-induced changes in lipid 
concentrations in blood are stimulated by the presence of the tumor. In 
the present study, the solid tumor weight was less than 1% of the body 
weight on the 21st day after the implantation of both 5×106 and 5×107 
SLC cells. Therefore, most of the parameters related to lipid metabolism 
examined in the present study might not be changed by SLC 
implantation. 
In the present study, the solid tumor was observed within a short time 
after SLC implantation and grew with time in a dose-dependent manner 
following the implantation of an increased amount of SLC cells, 
although the solid tumor stopped growing and then decreased in size 
until the 21st day after SLC implantation. The reason the implanted 
tumor cells stopped growing is unclear. The tumor cell has a very 
distinctive metabolism with the potential for infinite growth. The SLC 
cell originates from Donryu rats; it was therefore unlikely that rejection 
occurred in the present study because the SLC cells were implanted into 
Donryu rats. 
   In conclusion, SLC implantation in rats changes the total cholesterol 
concentration, and especially the HDL-cholesterol and esterified 
cholesterol concentrations, even if the tumor is small in size and 
regardless of the difference in the number of cells implanted. The 
mechanisms responsible for the observed changes in these serum 
cholesterol concentrations that occur as a result of the SLC implantation 
were not determined in the present study. Questions regarding the 
mechanisms of these changes in lipid levels in response to SLC 
implantation remain to be answered in a subsequent study. 
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Fig. 4. Liver lipid contents in normal and tumor-bearing rats. Each value represents the means for seven rats. Vertical bars indicate standard errors. 
C, normal rats group (Control); T6, tumor-bearing rats implanted 5×106 SLC cells group; T7, tumor-bearing rats implanted 5×107 SLC cells group. 
 
 
Fig. 5. Serum and liver thiobarbituric acid-reactive substance (TBARS) values in normal and tumor-bearing rats. Each value represents the means 
for seven rats. Vertical bars indicate standard errors. C, normal rats group (Control); T6, tumor-bearing rats implanted 5×106 SLC cells group; T7, 
tumor-bearing rats implanted 5×107 SLC cells group. 
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和文要旨   佐藤肺癌（SLC）移植ラットにおける血清および肝臓脂質レベルに対する担癌の影響を検討した。担癌ラットに
はSLC細胞を 5×106または 5×107移植し 21日間飼育した。血清総コレステロール濃度ならびにその中で高密度リポタンパク質
（HDL）コレステロールおよびエステル結合型コレステロール濃度が 5×106および 5×107の SLC 細胞の移植後対照群と比較し
て有意に低下した。その一方で，血清トリグリセリドおよび非エステル結合型脂肪酸，肝臓コレステロールおよびトリグリセリド
ならびに血清および肝臓チオバルビツール酸反応物質（TBARS 値）に SLC 移植による変化はみられなかった。固形癌が 5×106
または 5×107のSLC移植後それぞれ，3から6日後または 2から 4日後に観察されるようになり，時間の経過とともに増殖して
いった。しかし，SLCの移植およそ14日後に固形癌の増殖が止まり，移植21日目までその大きさが減少していった。移植21日
目の固形癌重量は5×106および5×107のSLC移植のいずれも体重の1％以下であった。SLC移植ラットにおいては，移植細胞数
の違いや固形癌の大きさの小ささにもかかわらず血清コレステロール濃度が変動し，脂質代謝異常が生じることが示唆された。 
